Today in the News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.

Press releases published on September 1, 2026

Sep. 1, 2026

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share

Indeterminate GlobeNewswire

Sep. 1, 2026

Atlanticus to Participate in B. Riley Securities Consumer & TMT Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Yatra Online, Inc. Board of Directors Unanimously Rejects Magna Holdings’ Unsolicited Partial Tender Offer

Indeterminate GlobeNewswire

Sep. 1, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

XT Exchange Welcomes HKB1, Bridging Blockchain With Global Commerce

Indeterminate GlobeNewswire

Sep. 1, 2026

Perfectly Imperfect by Gca Design Studio Wins Gold in A' Packaging Design Award

Indeterminate EIN Presswire

Sep. 1, 2026

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire

Sep. 1, 2026

LifeStance to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Indeterminate GlobeNewswire

Sep. 1, 2026

Sana Biotechnology to Present at September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Cytek Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

CAMP4 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Indeterminate GlobeNewswire

Sep. 1, 2026

Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Root Insurance and Carvana Extend Embedded Insurance Agreement

Indeterminate GlobeNewswire

Sep. 1, 2026

Bitdeer Announces Acquisition of 200 Acres Near Rockdale Facility in Milam County, Texas to Support AI/HPC Infrastructure Development

Indeterminate GlobeNewswire

Sep. 1, 2026

BBOT to Participate in Upcoming Investor Healthcare Conferences

Indeterminate GlobeNewswire